Prospective study of circulating angiogenic markers in prostate-specific antigen (PSA)-stable and PSA-progressive hormone-sensitive advanced prostate cancer

By Kohli M.   Kaushal V.   Spencer H.J.   Mehta P.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 765-769

Elsevier

Access to resources Recommend Favorite

PSA Levels and the Probability of Prostate Cancer on Biopsy

By Gretzer M.B.   Partin A.W.  

European Urology Supplements, Vol. 1, Iss. 6, 2002-09 ,pp. : 21-27

Elsevier

Access to resources Recommend Favorite

Age-specific serum levels of complexed PSA (CPSA) for prostate cancer screening

By Bartsch G.   Cheli C.   Levine R.   Klocker H.   Horninger W.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 186-186

Elsevier

Access to resources Recommend Favorite

PSA velocity for assessing prostate cancer risk in men with PSA levels between 2.0 and 4.0 ng/ml

By Fang J.   Metter E.J.   Landis P.   Carter H.B.  

Urology, Vol. 59, Iss. 6, 2002-06 ,pp. : 889-893

Elsevier

Access to resources Recommend Favorite

Serum prostate-specific antigen levels (PSA) in men without clinical evidence of prostate cancer: age-specific reference ranges for total PSA, free PSA, and percent free PSA - what's new in 1997

By Kalish L.A.   McKinlay J.B.  

Urology, Vol. 54, Iss. 6, 1999-12 ,pp. : 1022-1027

Elsevier

Access to resources Recommend Favorite